- Home
- CVKD vs LDTC Comparison
CVKD vs LDTC Comparison
Compare CVKD & LDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- LDTC
- Stock Information
- Founded
- CVKD 2022
- LDTC 2007
- Country
- CVKD United States
- LDTC Canada
- Employees
- CVKD N/A
- LDTC N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- LDTC Blank Checks
- Sector
- CVKD Health Care
- LDTC Finance
- Exchange
- CVKD Nasdaq
- LDTC Nasdaq
- Market Cap
- CVKD 33.7M
- LDTC 37.5M
- IPO Year
- CVKD 2023
- LDTC N/A
- Fundamental
- Price
- CVKD $13.54
- LDTC $0.33
- Analyst Decision
- CVKD Strong Buy
- LDTC Buy
- Analyst Count
- CVKD 1
- LDTC 2
- Target Price
- CVKD $32.00
- LDTC $3.00
- AVG Volume (30 Days)
- CVKD 22.0K
- LDTC 298.7K
- Earning Date
- CVKD 05-08-2025
- LDTC 05-14-2025
- Dividend Yield
- CVKD N/A
- LDTC N/A
- EPS Growth
- CVKD N/A
- LDTC N/A
- EPS
- CVKD N/A
- LDTC N/A
- Revenue
- CVKD N/A
- LDTC $413,610.00
- Revenue This Year
- CVKD N/A
- LDTC $906.25
- Revenue Next Year
- CVKD N/A
- LDTC $149.88
- P/E Ratio
- CVKD N/A
- LDTC N/A
- Revenue Growth
- CVKD N/A
- LDTC 141.86
- 52 Week Low
- CVKD $5.70
- LDTC $0.22
- 52 Week High
- CVKD $22.90
- LDTC $2.75
- Technical
- Relative Strength Index (RSI)
- CVKD 37.14
- LDTC 41.57
- Support Level
- CVKD $13.00
- LDTC $0.29
- Resistance Level
- CVKD $15.90
- LDTC $0.34
- Average True Range (ATR)
- CVKD 0.96
- LDTC 0.07
- MACD
- CVKD -0.13
- LDTC -0.02
- Stochastic Oscillator
- CVKD 16.62
- LDTC 9.02
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
About LDTC LeddarTech Holdings Inc.
LeddarTech Holdings Inc is a company that develops and provides comprehensive perception software solutions that enable the deployment of ADAS and autonomous driving (AD) applications. Its automotive-grade software applies AI and computer vision algorithms to generate accurate 3D models of the environment, allowing for decision-making and safer navigation. The company generates the majority of its revenue from France, Canada, and the United states.